MBNL and CELF proteins regulate alternative splicing of the skeletal muscle chloride channel CLCN1

Nucleic Acids Research

Volumn 37, Issue 19, 2009, Pages 6477-6490

  Kino, Yoshihiro ^a,b   Washizu, Chika ^a   Oma, Yoko ^b   Onishi, Hayato ^b   Nezu, Yuriko ^b   Sasagawa, Noboru ^b   Nukina, Nobuyuki ^a   Ishiura, Shoichi ^b  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE CHANNEL; MUSCLEBLIND LIKE PROTEIN; PROTEIN CELF; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; ENHANCER REGION; EXON; HUMAN; INTRON; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; REGULATORY MECHANISM; SKELETAL MUSCLE;

ALTERNATIVE SPLICING; ANIMALS; CHLORIDE CHANNELS; DNA REPEAT EXPANSION; EXONS; HUMANS; MICE; MUSCLE, SKELETAL; RNA SPLICE SITES; RNA, MESSENGER; RNA-BINDING PROTEINS;

EID: 71049162902     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkp681     Document Type: Article

References (57)

1. Harper,P.S. (2001) Myotonic Dystrophy, 3rd edn. WB Saunders, London.
2. Brook,J.D., McCurrach,M.E., Harley,H.G., Buckler,A.J., Church,D., Aburatani,H., Hunter,K., Stanton,V.P., Thirion,J.P., Hudson,T. et al. (1992) Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell, 68, 799-808.
3. Fu,Y.H., Friedman,D.L., Richards,S., Pearlman,J.A., Gibbs,R.A., Pizzuti,A., Ashizawa,T., Perryman,M.B., Scarlato,G., Fenwick,R.G. et al. (1993) Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science, 260, 235-238.
4. Mahadevan,M., Tsilfidis,C., Sabourin,L., Shutler,G., Amemiya,C., Jansen,G., Neville,C., Narang,M., Barcelo,J., O'Hoy,K. et al. (1992) Myotonic dystrophy mutation: An unstable CTG repeat in the 3′ untranslated region of the gene. Science, 255, 1253-1255.
5. Mankodi,A., Logigian,E., Callahan,L., McClain,C., White,R., Henderson,D., Krym,M. and Thornton,C.A. (2000) Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science, 289 1769-1773.
6. Liquori,C.L., Ricker,K., Moseley,M.L., Jacobsen,J.F., Kress,W., Naylor,S.L., Day,J.W. and Ranum,L.P. (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science, 293 864-867.
7. Taneja,K.L., McCurrach,M., Schalling,M., Housman,D. and Singer,R.H. (1995) Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J. Cell Biol., 128, 995-1002.
8. Davis,B.M., McCurrach,M.E., Taneja,K.L., Singer,R.H. and Housman,D.E. (1997) Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc. Natl Acad. Sci. USA, 94 7388-7393.
9. Philips,A.V., Timchenko,L.T. and Cooper,T.A. (1998) Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science, 280, 737-741.
10. Savkur,R.S., Philips,A.V. and Cooper,T.A. (2001) Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet., 29, 40-47.
11. Charlet-B,N., Savkur,R.S., Singh,G., Philips,A.V., Grice,E.A. and Cooper,T.A. (2002) Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol. Cell, 10, 45-53.
12. Mankodi,A., Takahashi,M.P., Jiang,H., Beck,C.L., Bowers,W.J., Moxley,R.T., Cannon,S.C. and Thornton,C.A. (2002) Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol. Cell 10, 35-44.
13. Kanadia,R.N., Johnstone,K.A., Mankodi,A., Lungu,C., Thornton,C.A., Esson,D., Timmers,A.M., Hauswirth,W.W. and Swanson,M.S. (2003) A muscleblind knockout model for myotonic dystrophy. Science, 302 1978-1980.
14. Kimura,T., Nakamori,M., Lueck,J.D., Pouliquin,P., Aoike,F., Fujimura,H., Dirksen,R.T., Takahashi,M.P., Dulhunty,A.F. and Sakoda,S. (2005) Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/ endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1. Hum. Mol. Genet., 14, 2189-2200.
15. Savkur,R.S., Philips,A.V., Cooper,T.A., Dalton,J.C., Moseley,M.L., Ranum,L.P. and Day,J.W. (2004) Insulin receptor splicing alteration in myotonic dystrophy type 2. Am. J. Hum. Genet., 74, 1309-1313.
16. Lin,X., Miller,J.W., Mankodi,A., Kanadia,R.N., Yuan,Y., Moxley,R.T., Swanson,M.S. and Thornton,C.A. (2006) Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum. Mol. Genet., 15, 2087-2097.
17. Ranum,L.P. and Cooper,T.A. (2006) RNA-mediated neuromuscular disorders. Annu. Rev. Neurosci., 29, 259-277.
18. Begemann,G., Paricio,N., Artero,R., Kiss,I., Perez-Alonso,M. and Mlodzik,M. (1997) muscleblind, a gene required for photoreceptor differentiation in Drosophila, encodes novel nuclear Cys3His-type zinc-finger-containing proteins. Development, 124, 4321-4331.
19. Artero,R., Prokop,A., Paricio,N., Begemann,G., Pueyo,I., Mlodzik,M., Perez-Alonso,M. and Baylies,M.K. (1998) The muscleblind gene participates in the organization of Z-bands and epidermal attachments of Drosophila muscles and is regulated by Dmef2. Dev. Biol., 195 131-143.
20. Fardaei,M., Rogers,M.T., Thorpe,H.M., Larkin,K., Hamshere,M.G., Harper,P.S. and Brook,J.D. (2002) Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum. Mol. Genet., 11, 805-814.
21. Miller,J.W., Urbinati,C.R., Teng-Umnuay,P., Stenberg,M.G., Byrne,B.J., Thornton,C.A. and Swanson,M.S. (2000) Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J., 19, 4439-4448.
22. Kino,Y., Mori,D., Oma,Y., Takeshita,Y., Sasagawa,N. and Ishiura,S. (2004) Muscleblind protein, MBNL1/EXP, binds specifically to CHHG repeats. Hum. Mol. Genet., 13, 495-507.
23. Hao,M., Akrami,K., Wei,K., De Diego,C., Che,N., Ku,J.H., Tidball,J., Graves,M.C., Shieh,P.B. and Chen,F. (2008) Muscleblind-like 2 (Mbnl2) -deficient mice as a model for myotonic dystrophy. Dev. Dyn., 237, 403-410.
24. Ho,T.H., Charlet-B,N., Poulos,M.G., Singh,G., Swanson,M.S. and Cooper,T.A. (2004) Muscleblind proteins regulate alternative splicing. EMBO J., 23, 3103-3112.
25. Dansithong,W., Paul,S., Comai,L. and Reddy,S. (2005) MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1. J. Biol. Chem., 280, 5773-5780.
26. Ladd,A.N., Charlet,N. and Cooper,T.A. (2001) The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol. Cell Biol., 21, 1285-1296.
27. Iakova,P., Wang,G.L., Timchenko,L., Michalak,M., Pereira-Smith,O.M., Smith,J.R. and Timchenko,N.A. (2004) Competition of CUGBP1 and calreticulin for the regulation of p21 translation determines cell fate. EMBO J., 23, 406-417.
28. Anant,S., Henderson,J.O., Mukhopadhyay,D., Navaratnam,N., Kennedy,S., Min,J. and Davidson,N.O. (2001) Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor. J. Biol. Chem., 276, 47338-47351.
29. Mukhopadhyay,D., Houchen,C.W., Kennedy,S., Dieckgraefe,B.K. and Anant,S. (2003) Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2. Mol. Cell 11, 113-126.
30. Timchenko,N.A., Cai,Z.J., Welm,A.L., Reddy,S., Ashizawa,T. and Timchenko,L.T. (2001) RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J. Biol. Chem., 276, 7820-7826.
31. Kuyumcu-Martinez,N.M., Wang,G.S. and Cooper,T.A. (2007) Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol. Cell, 28, 68-78.
32. Timchenko,N.A., Patel,R., Iakova,P., Cai,Z.J., Quan,L. and Timchenko,L.T. (2004) Overexpression of CUG triplet repeat-binding protein, CUGBP1, in mice inhibits myogenesis. J. Biol. Chem., 279, 13129-13139.
33. Ho,T.H., Bundman,D., Armstrong,D.L. and Cooper,T.A. (2005) Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. Hum. Mol. Genet., 14, 1539-1547.
34. Kleopa,K.A. and Barchi,R.L. (2002) Genetic disorders of neuromuscular ion channels. Muscle Nerve, 26, 299-325.
35. Pusch,M. (2002) Myotonia caused by mutations in the muscle chloride channel gene CLCN1. Hum. Mutat., 19, 423-434.
36. Berg,J., Jiang,H., Thornton,C.A. and Cannon,S.C. (2004) Truncated ClC-1 mRNA in myotonic dystrophy exerts a dominant-negative effect on the Cl current. Neurology, 63, 2371-2375.
37. Kanadia,R.N., Shin,J., Yuan,Y., Beattie,S.G., Wheeler,T.M., Thornton,C.A. and Swanson,M.S. (2006) Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy. Proc. Natl Acad. Sci. USA, 103, 11748-11753.
38. Wheeler,T.M., Lueck,J.D., Swanson,M.S., Dirksen,R.T. and Thornton,C.A. (2007) Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. J. Clin. Invest. 117, 3952-3957.
39. Orengo,J.P., Chambon,P., Metzger,D., Mosier,D.R., Snipes,G.J. and Cooper,T.A. (2008) Expanded CTG repeats within the DMPK 30 UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy. Proc. Natl Acad. Sci. USA, 105, 2646-2651.
40. Takahashi,N., Sasagawa,N., Usuki,F., Kino,Y., Kawahara,H., Sorimachi,H., Maeda,T., Suzuki,K. and Ishiura,S. (2001) Coexpression of the CUG-binding protein reduces DM protein kinase expression in COS cells. J. Biochem., 130, 581-587.
41. Carninci,P., Kasukawa,T., Katayama,S., Gough,J., Frith,MC., Maeda,N., Oyama,R., Ravasi,T., Lenhard,B., Wells,C. et al. (2005) The transcriptional landscape of the mammalian genome. Science, 309 1559-1563.
42. Niranjanakumari,S., Lasda,E., Brazas,R. and Garcia-Blanco,M.A. (2002) Reversible cross-linking combined with immuno-precipitation to study RNA-protein interactions in vivo. Methods, 26, 182-190.
43. Ladd,A.N., Nguyen,N.H., Malhotra,K. and Cooper,T.A. (2004) CELF6, a member of the CELF family of RNA-binding proteins, regulates muscle-specific splicing enhancer-dependent alternative splicing. J. Biol. Chem., 279, 17756-17764.
44. Warf,M.B. and Berglund,J.A. (2007) MBNL binds similar RNA structures in the CUG repeats of myotonic dystrophy and its pre-mRNA substrate cardiac troponin T. RNA, 13, 2238-2251.
45. Yuan,Y., Compton,S.A., Sobczak,K., Stenberg,M.G., Thornton,C.A., Griffith,J.D. and Swanson,M.S. (2007) Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs. Nucleic Acids Res., 35, 5474-5486.
46. Zuker,M. (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res., 31, 3406-3415.
47. Lueck,J.D., Lungu,C., Mankodi,A., Osborne,R.J., Welle,S.L., Dirksen,R.T. and Thornton,C.A. (2007) Chloride channelopathy in myotonic dystrophy resulting from loss of posttranscriptional regulation for CLCN1. Am. J. Physiol. Cell Physiol., 292, C1291-C1297.
48. Lueck,J.D., Mankodi,A., Swanson,M.S., Thornton,C.A. and Dirksen,R.T. (2007) Muscle chloride channel dysfunction in two mouse models of myotonic dystrophy. J. Gen. Physiol., 129, 79-94.
49. Seznec,H., Agbulut,O., Sergeant,N., Savouret,C., Ghestem,A., Tabti,N., Willer,J.C., Ourth,L., Duros,C., Brisson,E. et al. (2001) Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities. Hum. Mol. Genet. 10, 2717-2726.
50. O'Cochlain,D.F., Perez-Terzic,C., Reyes,S., Kane,G.C., Behfar,A., Hodgson,D.M., Strommen,J.A., Liu,X.K., van den Broek,W., Wansink,D.G. et al. (2004) Transgenic overexpression of human DMPK accumulates into hypertrophic cardiomyopathy, myotonic myopathy and hypotension traits of myotonic dystrophy. Hum. Mol. Genet., 13, 2505-2518.
51. Mahadevan,M.S., Yadava,R.S., Yu,Q., Balijepalli,S., Frenzel-McCardell,C.D., Bourne,T.D. and Phillips,L.H. (2006) Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy. Nat. Genet., 38, 1066-1070.
52. Chen,W., Wang,Y., Abe,Y., Cheney,L., Udd,B. and Li,Y.P. (2007) Haploinsuffciency for Znf9 in Znf9+/- mice is associated with multiorgan abnormalities resembling myotonic dystrophy. J. Mol. Biol., 368 8-17.
53. Yang,Y., Mahaffey,C.L., Bérubé,N., Maddatu,T.P., Cox,G.A. and Frankel,W.N. (2007) Complex seizure disorder caused by Brunol4 deficiency in mice. PLoS Genet., 3, e124.
54. Hino,S., Kondo,S., Sekiya,H., Saito,A., Kanemoto,S., Murakami,T., Chihara,K., Aoki,Y., Nakamori,M., Takahashi,M.P. et al. (2007) Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1. Hum. Mol. Genet., 16, 2834-2843.
55. Berget,S.M. (1995) Exon recognition in vertebrate splicing. J. Biol. Chem., 270, 2411-2314.
56. Blencowe,B.J. (2000) Exonic splicing enhancers: Mechanism of action, diversity and role in human genetic diseases. Trends Biochem. Sci. 25, 106-110.
57. Cartegni,L., Wang,J., Zhu,Z., Zhang,M.Q. and Krainer,A.R. (2003) ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res., 31, 3568-3571.